Presentations

Recent Presentations:

Date Details
April 6-8, 2017

Comprehensive Efficacy and Integrated Safety Results from the Late-phase Clinical Program of the Sufentanil Sublingual Tablet 30 mcg

Location: San Francisco, CA
Conference: Annual Regional Anesthesiology and Acute Pain Medicine Meeting
Presenter: Harold Minkowitz, MD
View: Poster
Mar 21-24, 2017

Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg for Management of Acute Traumatic Pain

Location: Brussels, Belgium
Conference: International Symposium on Intensive Care and Emergency Medicine
Presenter: Karen DiDonato, MSN, RN
View: Poster
March 16-19, 2017

Pharmacokinetics of a Single Dose of Sufentanil Sublingual Tablet 30 mcg vs. Intravenous Sufenta® 30 mcg in Healthy Volunteers

Location: Orlando, FL
Conference: American Academy of Pain Medicine
Presenter: Pamela Palmer, MD, PhD
View: Poster
Feb 15, 2017

Safety and Efficacy of the Sufentanil Sublingual Tablet 30mcg (SST 30mcg) for Treatment of Moderate-to-Severe Acute Pain in the Emergency Department

Location: Maui, HI
Conference: JAB Burn and Wound Care Symposium
Presenter: Karen DiDonato, MSN, RN
Dec 1, 2016

Acelrx Pharmaceuticals Analyst Day

Location: New York, NY
Presenter: Howie Rosen
Nov 17-19, 2016

A Phase 3 Open-Label Study of the Sufentanil Sublingual Tablet 30 MCG for Treatment of Acute Post-Operative Pain

Location: San Diego, CA
Conference: American Society of Regional Anesthesia and Pain Medicine
Presenter: Pamela Palmer, MD, PhD
View: Poster
Nov 4, 2016

The Sufentanil Sublingual 30mcg Tablet and Effect of BMI on Post-Operative Pain Management Following Outpatient Abdominal Surgery

Location: New Orleans, LA
Conference: The Obesity Society Annual Meeting
Presenter: Pamela Palmer, MD, PhD
Oct 29-Nov 2, 2016

Intravenous administration of morphine in the emergency room inflicts a substantial economic burden in the EU5

Location: Vienna Austria
Conference: International Society for Pharmacoeconomics and Outcomes Research
Oct 22-26, 2016

Efficacy and Safety of the Sufentanil Sublingual Tablet 30 mcg for Management of Acute Traumatic Pain in the Emergency Department

Location: Las Vegas, NV
Conference: National Commission on Correctional Health Care
View: Poster
October 3-5, 2016

Management of Acute Pain in Emergency Medicine: Sufentanil Sublingual Tablet 30 mcg

Location: New Orleans, LA
Conference: EMS World
Presenter: Pamela Palmer, MD, PhD
October 1-5, 2016

COST OF DELIVERING INTRAVENEOUS OPIOID ANALGESIA IN EMERGENCY DEPARTMENTS IN THE UNITED STATES

Location: Vienna, Austria
Conference: European Society of Emergency Medicine
Presenter: Pamela Palmer, MD, PhD
View: Poster
View: Poster
Sept 23, 2016

Phase 3 Results of Sublingual Sufentanil 30 mcg for the Management of Postoperative Pain following Abdominoplasty Surgery

Location: Los Angeles, CA
Conference: Plastic Surgery, The Meeting
Presenter: Shankar Lakshman, MD
Sept 12-16, 2016

Interim Analysis of an Open-label, Phase 3 Study of Sufentanil Sublingual 30 mcg Tablets in the Emergency Department

Location: Los Angeles, CA
Conference: Emergency Nurses Association
Presenter: Karen DiDonato, MSN, RN
View: Poster
Sep 7-10, 2016

Safety and Efficacy of Sufentanil Sublingual Tablet 30mcg by Surgery Type for the Treatment of Acute Pain Following Outpatient Abdominal Surgery

Location: Maastricht, Netherlands
Conference: European Society of Regional Anaesthesia and Pain Therapy
Presenter: Karen DiDonato, MSN, RN
View: Poster
Aug 28-Sept 1, 2016

Sufentanil Sublingual Tablet 30mcg for Acute Traumatic Pain in the Emergency Department

Location: Miami, FL
Conference: International Society for Burn Injuries
Presenter: Karen DiDonato, MSN, RN
Aug 15-18, 2016

Phase 3 Efficacy and Safety Results of Sufentanil Sublingual Tablet

Location: Orlando, FL
Conference: Military Health System Research Symposium
Presenter: Pamela Palmer, MD, PhD
Jul 30-Aug 4, 2016

Phase 3 Efficacy and Safety Results of Sufentanil Sublingual 30mcg Tablet for Management of Acute Traumatic Pain in Emergency Medicine

Location: Telluride, CO
Conference: Wilderness Medical Society
View: Poster
May 28-30, 2016

Safety and Efficacy of Sufentanil Sublingual 30 mcg Tablets for the Treatment of Acute Pain Following Outpatient Surgery

Location: London, England
Conference: European Anaesthesiology Congress
Presenter: Karen DiDonato, MSN, RN
View: Poster
May 21-25, 2016

Cost of Delivering Intraveneous Opioid Analgesian in Emergency Departments in the United States

Location: Washington, DC
Conference: International Society for Pharmacoeconomics and Outcomes Research
Presenter: Karen DiDonato, MSN, RN
View: Poster
May 5-7, 2016

Safety and Efficacy of Sufentanil Sublingual 30mcg Tablets by Surgery Type for the Treatment of Acute Pain Following Outpatient Abdominal Surgery

Location: Orlando, FL
Conference: Society for Ambulatory Anesthesia
Presenter: Pamela Palmer, MD, PhD
View: Poster
March 31-April 2, 2016

A Phase 3, Open-label Study of Sufentanil Sublingual 30 mcg Tablets for the Treatment of Acute Pain in the Emergency Department

Location: New Orleans, LA
Conference: American Society of Regional Anesthesia and Pain Medicine
Presenter: Pamela Palmer, MD, PhD
Feb 14, 2016

Phase 3 Efficacy and Safety Results of Sublingual Sufentanil 30 mcg for the Management of Acute Moderate to Severe Pain

Location: Maui, HI
Conference: JAB Burn and Wound Care Symposium
Presenter: Karen DiDonato, MSN, RN
January 28-29, 2016

Efficacy and Safety of Sublingual Sufentanil 30 mcg for the Management of Acute Pain Following Ambulatory Surgery

Location: Paris, FR
Conference: European Congress of Ambulatory Surgery
Presenter: Pamela Palmer, MD, PhD